Document is current
Any future updates will be listed below
-
Authors
Hung, King L. https://orcid.org/0000-0002-3662-4662
Jones, Matthew G.
Wong, Ivy Tsz-Lo https://orcid.org/0000-0002-9761-3422
Curtis, Ellis J.
Lange, Joshua T.
He, Britney Jiayu https://orcid.org/0000-0001-8989-1521
Luebeck, Jens https://orcid.org/0000-0003-4391-979X
Schmargon, Rachel https://orcid.org/0009-0009-3535-7185
Scanu, Elisa
Brückner, Lotte https://orcid.org/0000-0002-6155-2277
Yan, Xiaowei https://orcid.org/0000-0002-4846-8812
Li, Rui
Gnanasekar, Aditi
Chamorro González, Rocío https://orcid.org/0000-0002-5653-7259
Belk, Julia A. https://orcid.org/0000-0003-4724-6158
Liu, Zhonglin
Melillo, Bruno https://orcid.org/0000-0002-9708-5287
Bafna, Vineet
Dörr, Jan R.
Werner, Benjamin https://orcid.org/0000-0002-6857-8699
Huang, Weini https://orcid.org/0000-0002-9016-2665
Cravatt, Benjamin F. https://orcid.org/0000-0001-5330-3492
Henssen, Anton G. https://orcid.org/0000-0003-1534-778X
Mischel, Paul S. https://orcid.org/0000-0002-4560-2211
Chang, Howard Y. https://orcid.org/0000-0002-9459-4393
- License Information
-
More Information
Article History
Received: 20 April 2023
Accepted: 19 July 2024
First Online: 6 November 2024
Competing interests
: H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, Cartography Biosciences and Orbital Therapeutics, and an advisor of 10x Genomics, Arsenal Biosciences, Chroma Medicine and Spring Discovery. V.B. is a co-founder, paid consultant, scientific advisory board member and has equity interest in Boundless Bio and Abterra. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. M.G.J. consults for and holds equity in Vevo Therapeutics. P.S.M. and B.F.C. are co-founders and advisors of Boundless Bio. The other authors declare no competing interests.
